Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Home CompaniesCypherpunk Technologies Inc.

Cypherpunk Technologies Inc.

Financial Services Asset Management
PortfolioPortfolio WatchlistWatchlist
Company price
2.125 USD -0.23 ( 9.96%)
Last update at 2026-11-10T17:48:00Z
VOLUME
12587371
Market Cap
78.17M
P/E
12.41

Momentum Score

…

Cypherpunk Technologies Inc., a privacy technology company, implements a digital asset strategy anchored by Zcash in the United States. The company is involved in identifying, developing, investing in, acquiring, and building privacy-enhancing technologies; and accumulating digital assets, such as ZCash. It also develops biomarker-targeted antibody therapies for patients with cancer and other diseases comprising DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which has completed Phase 2 study for the treatment of colorectal cancer; and FL-501, a monoclonal antibody inhibiting the GDF-15 protein, which is in preclinical development to treat cancer cachexia, hyperemesis gravidarum and pregnancy-related nausea and vomiting, and other diseases associated with aging and frailty. The company was formerly known as Leap Therapeutics, Inc. and changed its name to Cypherpunk Technologies Inc. in November 2025. Cypherpunk Technologies Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
2.06
Low
2.45
High
52 Week Price Range
0.23
Low
3.70
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public disclosure for Cypherpunk Technologies Inc. (CYPH) is limited and I cannot reliably summarize its business operations, industry positioning, or material growth drivers without consulting the company's recent filings. Investors seeking exposure to any claimed privacy- or blockchain-related initiatives should consult audited filings and investor presentations to assess long-term prospects and avoid assumptions.
Material risks include regulatory and legal uncertainty around privacy and blockchain technologies, commercially unproven operations with execution and financing risk, and limited trading liquidity that could amplify share volatility.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
2.36
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
0.00
ROE
5.11%
Net Debt
-14.00M
ROCE
-23.04%
Diluted EPS TTM
0.07

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 10.08M -66.97M -81.41M -54.45M -40.61M
Net income 4.82M -67.56M -81.41M -54.60M -40.59M
Selling general administrative 10.87M 12.85M 13.81M 11.80M 10.77M
Selling and marketing expenses - - 0.43M - -
Gross profit - - -0.43M - 1.50M
Reconciled depreciation 0.00M 0.01M 0.01M 0.02M 0.03M
Ebit - -70.06M -81.41M -54.40M -40.57M
Ebitda -36.54M -70.05M -80.99M -54.38M -40.54M
Depreciation and amortization - 0.01M 0.43M 0.02M 0.03M
Operating income -36.54M -70.06M -87.04M -56.76M -41.43M
Other operating expenses 36.54M 70.06M 87.04M 56.76M 42.93M
Interest expense 0.02M 0.00M 0.00M 0.05M 0.04M
Tax provision 5.25M 0.58M 0.00M 0.15M -0.02M
Interest income 0.92M 3.13M 4.03M 0.93M 0.01M
Net interest income 0.89M 3.13M 4.03M 0.87M -0.03M
Income tax expense 5.25M 0.58M - 0.15M -0.02M
Total revenue 0.00M 0.00M 0.00M 0.00M 1.50M
Total operating expenses 36.54M 70.06M 86.61M 56.76M 42.93M
Cost of revenue - - 0.43M - -
Total other income expense net 46.62M 3.09M 5.63M 2.31M 0.81M
Net income from continuing ops 4.82M -67.56M -81.41M -54.60M -40.59M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 163.18M 49.12M 72.83M 58.09M 117.91M
Intangible assets - - - 0.03M -
Other current assets 0.04M 0.09M 0.18M 6.70M 0.77M
Total liab 9.68M 14.08M 12.68M 3.45M 10.02M
Total stockholder equity 153.51M 35.05M 60.14M 54.64M 107.89M
Other current liab 2.07M 8.54M 5.96M 1.31M 5.37M
Common stock 0.08M 0.04M 0.03M 0.14M 0.09M
Capital stock 0.08M 0.04M 0.03M 0.01M 0.09M
Retained earnings -462.55M -467.37M -399.58M -105.93M -263.57M
Cash 14.04M 47.25M 70.64M 20.99M 114.92M
Total current liabilities 4.56M 14.08M 12.68M 3.12M 9.99M
Net debt -14.00M -46.98M -70.38M -20.47M -114.45M
Short term debt 0.04M 0.27M 0.26M 0.27M 0.43M
Short long term debt total 0.04M 0.27M 0.26M 0.52M 0.47M
Other stockholder equity 616.22M 502.50M 459.59M 160.43M 371.64M
Total current assets 162.08M 48.04M 71.60M 53.22M 116.87M
Short term investments - - - 22.76M -
Net receivables 148.01M 0.70M 0.77M 1.36M 1.19M
Inventory - - - 1.40M -
Accounts payable 1.98M 4.74M 6.46M 1.54M 4.19M
Accumulated other comprehensive income -0.10M -0.12M 0.11M 0.00M -0.27M
Non currrent assets other 0.91M 0.82M 0.97M 4.33M 0.38M
Non current assets total 1.10M 1.08M 1.23M 4.88M 1.04M
Capital lease obligations 0.04M 0.27M 0.26M 0.68M 0.47M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - 0.00M 48.97M 0.00M 0.00M
Total cashflows from investing activities -97.00M - 48.97M - -
Total cash from financing activities 107.65M 37.18M -0.03M -0.21M 98.03M
Net income 4.82M -67.56M -81.41M -54.60M -40.59M
Change in cash -33.21M -23.39M 5.14M -49.42M 62.84M
Begin period cash flow 47.25M 70.64M 65.50M 114.92M 52.07M
End period cash flow 14.04M 47.25M 70.64M 65.50M 114.92M
Total cash from operating activities -43.90M -60.30M -43.75M -49.04M -35.16M
Issuance of capital stock 108.69M 40.00M 0.00M 0.00M 97.22M
Depreciation 0.00M 0.01M 0.01M 0.02M 0.03M
Other cashflows from investing activities -97.00M - -1.39M - -
Change to inventory - - - - 1.16M
Change to account receivables 0.15M - 1.30M -1.01M -1.16M
Sale purchase of stock - 0.00M -0.00M 0.00M -
Other cashflows from financing activities 107.65M -2.81M -0.03M -0.21M 0.81M
Capital expenditures 97.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital -8.56M 1.29M 2.51M -0.65M 1.01M
Stock based compensation 4.90M 5.50M 5.13M 5.18M 3.48M
Other non cash items -50.19M 0.46M 30.01M 1.01M 0.53M
Free cash flow -43.90M -60.30M -43.75M -49.04M -35.16M

Peer Comparison*

Sector: Financial Services Industry: Asset Management

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to EBITDA (x)
CYPH
Cypherpunk Technologies Inc.		 -0.23
9.96%		 2.12 12.41 - 160.10 0.51 6.35
BLK
BlackRock Inc		 0.60
0.05%		 1215.31 26.25 19.57 6.33 2.90 17.13
BX
Blackstone Group Inc		 -1.94
1.56%		 122.11 33.20 20.12 11.05 11.56 15.74
IVSBF
Investor AB ser. B		 -
-%		 44.11 4.67 3.83 3.78 1.13 1.68
KKR
KKR & Co. Inc.		 0.47
0.48%		 98.56 32.68 13.66 3.58 3.22 1.47

Profile*

Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc., a privacy technology company, implements a digital asset strategy anchored by Zcash in the United States. The company is involved in identifying, developing, investing in, acquiring, and building privacy-enhancing technologies; and accumulating digital assets, such as ZCash. It also develops biomarker-targeted antibody therapies for patients with cancer and other diseases comprising DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which has completed Phase 2 study for the treatment of colorectal cancer; and FL-501, a monoclonal antibody inhibiting the GDF-15 protein, which is in preclinical development to treat cancer cachexia, hyperemesis gravidarum and pregnancy-related nausea and vomiting, and other diseases associated with aging and frailty. The company was formerly known as Leap Therapeutics, Inc. and changed its name to Cypherpunk Technologies Inc. in November 2025. Cypherpunk Technologies Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.

47 Thorndike Street, Cambridge, MA, United States, 02141

617 714 0360

https://www.cypherpunk.com

6

Name Title Year Born
Mr. Douglas E. Onsi J.D. CFO, General Counsel, Treasurer & Secretary, President, CEO & Director 1969
Mr. Will McEvoy Chief Investment Officer & Director NA
Mr. Mark O'Mahony Chief Manufacturing Officer 1971

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DAR
GBX 8.30
+23.42%
VTY
GBX 276.20
+8.23%
GTCO
GBX 0.09
+6.98%
GLV
GBX 2.34
+6.36%
BUR
GBX 249.20
+5.95%
TMI
GBX 0.72
-6.49%
HSBA
GBX 1291.40
-5.42%
RKT
GBX 5218.00
-4.85%
TGA
GBX 643.00
-4.03%
RKH
GBX 61.70
-3.89%

Equity Sectors*

  • Basic Materials

    -1.70%

  • Communication Services

    +0.33%

  • Consumer Cyclical

    +0.45%

  • Consumer Defensive

    -0.56%

  • Energy

    -0.25%

  • Financial Services

    +0.49%

  • Healthcare

    +0.20%

  • Industrials

    +0.74%

  • Real Estate

    +1.71%

  • Technology

    -2.81%

  • Utilities

    +0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Cookies on this website

We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.

Essential cookies

These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.

Analytics cookies

We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.

Marketing cookies

These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.

Support

Hi! How can we help you today?

Loading…